Enquirer Consulting Group

Reachable Buyer Map

Prepared for Ankit Rathi · Specialty Enzymes and Probiotics · August 2026
This covers the US market, the largest single one for ingredient sales, and the shape repeats in the other major markets. Your market has an unusual feature: the people who choose your ingredient and the people who buy it mostly work at different companies. This map is who signs inside each segment, roughly how many companies sit there, and where the reach usually runs thinnest. It describes the market rather than your business, and there is nothing to buy at the end of it.
Contract manufacturers and private label producers
The layer that physically buys the ingredient, blends it and ships the finished bottle. Slow to qualify a new supplier and slow to drop one, which makes this the segment where the work is front loaded and the relationship long.
Who signs: vice president of research and development, formulation chemist, procurement or sourcing manager, quality director.
900 to 1,400
US facilities registered to manufacture dietary supplements; facilities rather than companies, so a group with three plants counts three times
Supplement and nutraceutical brand owners
The layer that chooses which branded ingredient goes on the label, and the reason this map exists. A brand that outsources production never registers as a manufacturer, so it is invisible in every register that lists plants. That is not a small gap. It is most of the market, and it is the half that decides.
Who signs: founder or chief executive at emerging brands, vice president of product, head of research and development, brand or category marketing lead.
Not separately enumerated
no public register lists brand owners who outsource production; reached by name, one company at a time
Functional food and beverage plants
Bakery, brewing and beverage, dairy, juice and starch processing, where an enzyme is a process aid rather than a label claim. Longer cycles and a technical buyer, but volumes are steady once the plant is qualified and the switching cost runs against the incumbent, not you.
Who signs: plant or process engineer, research and development manager, quality assurance director, procurement manager.
3,000 to 4,500
US food and beverage manufacturing plants in the categories where enzymes act as process aids
Sports and active nutrition brands
Fast product cycles, ingredient stories that reach the consumer directly, and a buyer who will put a branded ingredient on the front of the pack. The category is defined by positioning rather than by registration, which is why no clean count exists for it and why it stays underworked.
Who signs: founder, head of product development, formulation lead, brand marketing director.
No clean public register
identified by brand and by product line rather than counted
Pet and equine supplement makers
Small by count and unusually loyal by behavior once a formula is set. The regulatory route is different from human nutrition, so this segment tends to be worked by people who already understand it, and ignored by everyone else.
Who signs: product development manager, technical or veterinary lead, procurement manager, and at owner-run brands the founder.
300 to 600
US companies supplying animal health and companion animal supplements at established scale
Ingredient distributors and brokers
A channel and a competitor at the same time. Distributors carry the reach into small brands that would never be economical to serve directly, and they also stand between you and the person who chose the ingredient in the first place.
Who signs: category or product manager, technical sales director, purchasing lead.
250 to 450
US distributors and brokers serving the nutrition and food ingredient trade

Where the openings are

1
The company that specifies is not the company that buys. A branded ingredient is chosen by the brand owner and purchased by the contract manufacturer. Every off the shelf list reaches the second one, because plants register and brands do not. Working the specifier layer takes identification rather than purchase, which is exactly why it stays open.
2
Reformulation is a moment, not a cycle. A new line, a label change, a supplier that failed a test, a claim that needs support. Those moments are visible from outside if someone is watching several thousand companies for the trigger. They are invisible if you are waiting for a request to arrive.
3
Three functions inside one account, and they do not talk. Research and development decides whether the ingredient works, procurement decides whether it clears, and marketing decides whether the ingredient brand earns space on the label. A channel that reaches one of those three keeps having the same conversation.
4
This is a distribution problem, not a credibility one. The science and the certifications are published and they speak for themselves. What tends to decide this category is the machinery that puts a supplier in front of several thousand named formulators and product leads on a schedule, and tracks what comes back. That is the part we build, run, and hand over.
Built from public registries, counts banded deliberately. Registrations count facilities rather than companies, so a group with several plants appears more than once, and companies that own a brand but outsource production do not appear at all. Sector codes are self reported. Very small and owner only operations are not published in this data, so these figures describe established companies rather than the whole market.
ENQUIRER CONSULTING GROUP
enquirerconsulting.com